Muthulekha Swamydas, Ph.D.

2007 Anatomy and Cell Biology Wayne State University, Detroit, MI, United States 
Cell Biology
"Muthulekha Swamydas"


Sign in to add mentor
Robert P. Skoff grad student 2007 Wayne State
 (Role of hormones in the sexual dimorphism of oligodendrocytes.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Break TJ, Oikonomou V, Dutzan N, et al. (2021) Response to Comments on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections". Science (New York, N.Y.). 373: eabi8835
Break TJ, Oikonomou V, Dutzan N, et al. (2021) Aberrant type 1 immunity drives susceptibility to mucosal fungal infections. Science (New York, N.Y.). 371
Myles IA, Castillo CR, Barbian KD, et al. (2020) Therapeutic responses to in atopic dermatitis may involve lipid-mediated TNF-related epithelial repair. Science Translational Medicine. 12
Wurster S, Robinson P, Albert ND, et al. (2020) PD-1 blockade improves survival and fungal clearance, induces pro-inflammatory lung cytokines and synergizes with caspofungin in a pulmonary aspergillosis model. The Journal of Infectious Diseases
Rigoni R, Fontana E, Dobbs K, et al. (2020) Cutaneous barrier leakage and gut inflammation drive skin disease in Omenn Syndrome. The Journal of Allergy and Clinical Immunology
Yamanaka D, Takatsu K, Kimura M, et al. (2020) Development of a novel β-1,6-glucan-specific detection system using functionally modified recombinant endo-β-1,6-glucanase. The Journal of Biological Chemistry
Ferré EMN, Break TJ, Burbelo PD, et al. (2019) Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance. Science Translational Medicine. 11
Drummond RA, Swamydas M, Oikonomou V, et al. (2019) CARD9 microglia promote antifungal immunity via IL-1β- and CXCL1-mediated neutrophil recruitment. Nature Immunology. 20: 559-570
Hsu AP, Donkó A, Arrington ME, et al. (2019) Dominant activating RAC2 mutation with lymphopenia, immunodeficiency and cytoskeletal defects. Blood
Drummond RA, Zahra FT, Natarajan M, et al. (2018) GM-CSF Therapy in Human CARD9 Deficiency. The Journal of Allergy and Clinical Immunology
See more...